glp-1 drugs history Market Overview: Agonists and the Obesity Market | Blog GLP-1 Drug Market: the rapid

Its important to adhere to the schedule and follow instructions closely to maximize the benefits of the medication

But many patients with diabetes also take GLP-1 agonists to support weight loss, as weight loss itself can improve diabetes outcomes

Other symptoms then appear, including nausea, vomiting, weakness, sweating, and hypotension

Global GLP-1 Receptor Agonist Market Recent Developments: 2025: Eli Lilly's once-daily oral GLP-1 agonist Orforglipron completed Phase III trials, delivering meaningful weight loss and strong blood-glucose (A1C) reduction

Sources American Diabetes Association

Furthermore, the review explores novel drug delivery strategies, such as microsphere encapsulation, injectable hydrogels, Fc-fusion, and oral small-molecule formulations, aimed at achieving sustained and controlled release to reduce dosing frequency and improve patient compliance